{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T08:28:49Z","timestamp":1788251329513,"version":"build-2803163510"},"reference-count":148,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,5,26]],"date-time":"2027-05-26T00:00:00Z","timestamp":1811289600000},"content-version":"am","delay-in-days":390,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jcf.2026.03.026","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T20:43:43Z","timestamp":1774989823000},"page":"417-425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Changes in nutritional priorities and management in people with CF"],"prefix":"10.1016","volume":"25","author":[{"given":"Jessica A.","family":"Alvarez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Jane","family":"Schwarzenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0371-0986","authenticated-orcid":false,"given":"Nicole","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jcf.2026.03.026_bib0001","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jada.2008.02.020","article-title":"Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review","volume":"108","author":"Stallings","year":"2008","journal-title":"J Am Diet Assoc"},{"key":"10.1016\/j.jcf.2026.03.026_bib0002","article-title":"Nutritional status in the era of highly effective CFTR modulators","volume":"59","author":"Bass","year":"2024"},{"issue":"9","key":"10.1016\/j.jcf.2026.03.026_bib0003","doi-asserted-by":"crossref","DOI":"10.3390\/genes16091049","article-title":"Gut dysbiosis driven by CFTR gene mutations in cystic fibrosis patients: from genetic disruption to multisystem consequences and microbiota modulation","volume":"16","author":"Paw\u0142owska","year":"2025","journal-title":"Genes (Basel)"},{"issue":"3","key":"10.1016\/j.jcf.2026.03.026_bib0004","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.clnu.2016.03.004","article-title":"ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis","volume":"35","author":"Turck","year":"2016","journal-title":"Clinic Nutrition"},{"key":"10.1016\/j.jcf.2026.03.026_bib0005","article-title":"Academy of nutrition and dietetics: 2020 cystic fibrosis evidence analysis center evidence-based nutrition practice guideline","author":"McDonald","year":"2020","journal-title":"J Acad Nutr Diet"},{"issue":"2","key":"10.1016\/j.jcf.2026.03.026_bib0006","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.clnu.2023.12.017","article-title":"ESPEN-ESPGHAN-ECFS guideline on nutrition care for cystic fibrosis","volume":"43","author":"Wilschanski","year":"2024","journal-title":"Clinic Nutrition"},{"issue":"5","key":"10.1016\/j.jcf.2026.03.026_bib0007","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.jcf.2023.05.010","article-title":"Nutritional considerations for a new era: a CF foundation position paper","volume":"22","author":"Leonard","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.026_bib0008","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jcf.2023.12.002","article-title":"Standards for the care of people with cystic fibrosis; establishing and maintaining health","volume":"23","author":"Southern","year":"2024","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.03.026_bib0009","article-title":"Predicted lean body mass, fat mass, and all cause and cause specific mortality in men: prospective US cohort study","volume":"362","author":"Lee","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.jcf.2026.03.026_bib0010","article-title":"Low lean mass and all-cause mortality risk in the middle-aged and older population: a dose-response meta-analysis of prospective cohort studies. Systematic Review","volume":"12","author":"Li","year":"2025","journal-title":"Front Med"},{"issue":"3","key":"10.1016\/j.jcf.2026.03.026_bib0011","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/ajcn\/nqaa339","article-title":"Relation of body fat mass and fat-free mass to total mortality: results from 7 prospective cohort studies","volume":"113","author":"Sedlmeier","year":"2021","journal-title":"Am J Clin Nutr."},{"issue":"4","key":"10.1016\/j.jcf.2026.03.026_bib0012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194697","article-title":"Muscle mass, BMI, and mortality among adults in the United States: a population-based cohort study","volume":"13","author":"Abramowitz","year":"2018","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.jcf.2026.03.026_bib0013","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jcf.2023.06.003","article-title":"Body composition and body mass index measures from 8 to 18 years old in children with cystic fibrosis","volume":"22","author":"Tran","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"5","key":"10.1016\/j.jcf.2026.03.026_bib0014","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.ajcnut.2025.09.019","article-title":"Relationship between skeletal muscle indicators and clinical outcomes in cystic fibrosis is modified by adiposity and CFTR modulator use: a cross-sectional analysis","volume":"122","author":"Gonzalez Ramirez","year":"2025","journal-title":"Am J Clin Nutr."},{"key":"10.1016\/j.jcf.2026.03.026_bib0015","doi-asserted-by":"crossref","DOI":"10.1177\/20420188251328210","article-title":"Cystic fibrosis-related bone disease: an update on screening, diagnosis, and treatment","volume":"16","author":"Cobb","year":"2025","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.jcf.2026.03.026_bib0016","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/jcsm.12147","article-title":"Welcome to the ICD-10 code for sarcopenia","volume":"7","author":"Anker","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"8","key":"10.1016\/j.jcf.2026.03.026_bib0017","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1159\/000528561","article-title":"Frailty: pathophysiology, theoretical and operational definition(s), impact, prevalence, management and prevention, in an increasingly economically developed and ageing world","volume":"69","author":"Doody","year":"2023","journal-title":"Gerontology"},{"key":"10.1016\/j.jcf.2026.03.026_bib0018","doi-asserted-by":"crossref","DOI":"10.1002\/ncp.70087","article-title":"Interrelationships among handgrip strength, body composition, physical activity, and quality of life in adults with cystic fibrosis: a cross-sectional study","author":"Crain","year":"2026","journal-title":"Nutr Clin Pract"},{"issue":"3","key":"10.1016\/j.jcf.2026.03.026_bib0019","doi-asserted-by":"crossref","DOI":"10.1002\/ppul.71044","article-title":"Peripheral muscle function and body composition in people with cystic fibrosis on elexacaftor\/tezacaftor\/ivacaftor: a cross-sectional single-centre study","volume":"60","author":"Clayton","year":"2025","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2026.03.026_bib0020","article-title":"Body composition in individuals with cystic fibrosis","volume":"26","author":"Soltman","year":"2021","journal-title":"J Clin Transl Endocrinol"},{"issue":"2","key":"10.1016\/j.jcf.2026.03.026_bib0021","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13020585","article-title":"Cystic fibrosis in adults: a paradigm of frailty syndrome? An observational study","volume":"13","author":"Iacotucci","year":"2024","journal-title":"J Clin Med"},{"issue":"11","key":"10.1016\/j.jcf.2026.03.026_bib0022","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.healun.2022.07.017","article-title":"Frailty predicts outcomes in cystic fibrosis patients listed for lung transplantation","volume":"41","author":"Koutsokera","year":"2022","journal-title":"J Heart Lung Transplant"},{"issue":"6","key":"10.1016\/j.jcf.2026.03.026_bib0023","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jcf.2016.05.004","article-title":"Bioelectrical impedance in young patients with cystic fibrosis: validation of a specific equation and clinical relevance","volume":"15","author":"Charatsi","year":"2016","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.026_bib0024","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/jcsm.12860","article-title":"Phase angle from bioelectrical impedance analysis is a useful indicator of muscle quality","volume":"13","author":"Akamatsu","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"3","key":"10.1016\/j.jcf.2026.03.026_bib0025","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s11154-022-09772-3","article-title":"Role of phase angle in older adults with focus on the geriatric syndromes sarcopenia and frailty","volume":"24","author":"Norman","year":"2023","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.jcf.2026.03.026_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2024.112425","article-title":"Impact of CFTR modulator therapy on body composition as assessed by thoracic computed tomography: a follow-up study","volume":"123","author":"Navas-Moreno","year":"2024","journal-title":"Nutrition"},{"issue":"3","key":"10.1016\/j.jcf.2026.03.026_bib0027","doi-asserted-by":"crossref","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.026_bib0028","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"issue":"13","key":"10.1016\/j.jcf.2026.03.026_bib0029","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1080\/09593985.2021.1973165","article-title":"Relationship between peripheral muscle strength, exercise capacity and body composition in children and adolescents with cystic fibrosis","volume":"38","author":"Cardoso","year":"2022","journal-title":"Physiother Theory Pract"},{"issue":"11","key":"10.1016\/j.jcf.2026.03.026_bib0030","doi-asserted-by":"crossref","DOI":"10.3390\/nu13114107","article-title":"Handgrip strength: associations with clinical variables, body composition, and bone mineral density in adults with cystic fibrosis","volume":"13","author":"Contreras-Bolivar","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.jcf.2026.03.026_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2025.108624","article-title":"Peripheral muscle strength and lung function in adults with cystic fibrosis","volume":"252","author":"Lewis","year":"2026","journal-title":"Respir Med"},{"issue":"6","key":"10.1016\/j.jcf.2026.03.026_bib0032","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/jpen.2366","article-title":"Guidance for assessment of the muscle mass phenotypic criterion for the global leadership initiative on malnutrition diagnosis of malnutrition","volume":"46","author":"Compher","year":"2022","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"16","key":"10.1016\/j.jcf.2026.03.026_bib0033","doi-asserted-by":"crossref","DOI":"10.3390\/nu14163377","article-title":"Usefulness of muscle ultrasonography in the nutritional assessment of adult patients with cystic fibrosis","volume":"14","author":"Sanchez-Torralvo","year":"2022","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.jcf.2026.03.026_bib0034","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1590\/1984-0462\/;2018;36;4;00015","article-title":"The use of ultrasonography to evaluate muscle thickness and subcutaneous fat in children and adolescents with cystic fibrosis","volume":"36","author":"Souza","year":"2018","journal-title":"Rev Paul Pediatr"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.026_bib0035","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12890-023-02398-4","article-title":"Computed tomography body composition and clinical outcomes following lung transplantation in cystic fibrosis","volume":"23","author":"Jennerich","year":"2023","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jcf.2026.03.026_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2024.112425","article-title":"Impact of CFTR modulator therapy on body composition as assessed by thoracic computed tomography: a follow-up study","volume":"123","author":"Navas-Moreno","year":"2024","journal-title":"Nutrition"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.026_bib0037","doi-asserted-by":"crossref","first-page":"9465","DOI":"10.1038\/s41598-024-59622-2","article-title":"Elexacaftor\/tezacaftor\/ivacaftor influences body composition in adults with cystic fibrosis: a fully automated CT-based analysis","volume":"14","author":"Westh\u00f6lter","year":"2024","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.jcf.2026.03.026_bib0038","doi-asserted-by":"crossref","first-page":"668","DOI":"10.4329\/wjr.v16.i11.668","article-title":"Ultra-low-dose chest computed tomography with model-based iterative reconstruction in the analysis of solid pulmonary nodules: a prospective study","volume":"16","author":"O'Regan","year":"2024","journal-title":"World J Radiol"},{"issue":"18","key":"10.1016\/j.jcf.2026.03.026_bib0039","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.3390\/nu17182940","article-title":"Integrating imaging and nutrition: chest CT muscle analysis in adults with cystic fibrosis","volume":"17","author":"Soria-Utrilla","year":"2025","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.jcf.2026.03.026_bib0040","article-title":"Impact of elexacaftor-tezacaftor-ivacaftor on muscle composition in cystic fibrosis: an AI-assisted chest CT-based body composition analysis","volume":"13","author":"Welsner","year":"2025","journal-title":"Med Sci (Basel)"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.026_bib0041","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-99522-7","article-title":"Development of an artificial intelligence powered software for automated analysis of skeletal muscle ultrasonography","volume":"15","author":"Rivera","year":"2025","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.jcf.2026.03.026_bib0042","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.clnu.2022.02.001","article-title":"Guidance for assessment of the muscle mass phenotypic criterion for the global leadership initiative on malnutrition (GLIM) diagnosis of malnutrition","volume":"41","author":"Barazzoni","year":"2022","journal-title":"Clinical nutrition"},{"issue":"6","key":"10.1016\/j.jcf.2026.03.026_bib0043","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1007\/s00198-017-3980-9","article-title":"Nutrition and physical activity in the prevention and treatment of sarcopenia: systematic review","volume":"28","author":"Beaudart","year":"2017","journal-title":"Osteoporos Int"},{"issue":"4","key":"10.1016\/j.jcf.2026.03.026_bib0044","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/advances\/nmab032","article-title":"Healthy aging-nutrition matters: start early and screen often","volume":"12","author":"Roberts","year":"2021","journal-title":"Adv Nutr"},{"issue":"8","key":"10.1016\/j.jcf.2026.03.026_bib0045","doi-asserted-by":"crossref","first-page":"6874","DOI":"10.3390\/nu7085311","article-title":"Protein requirements and recommendations for older people: a review","volume":"7","author":"Nowson","year":"2015","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.jcf.2026.03.026_bib0046","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jcf.2022.05.009","article-title":"Change in exercise capacity measured by cardio-pulmonary exercise testing (CPET) in Danish people with cystic fibrosis after initiation of treatment with Lumacaftor\/Ivacaftor and Tezacaftor\/Ivacaftor","volume":"21","author":"Rysgaard","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.026_bib0047","doi-asserted-by":"crossref","DOI":"10.1111\/sms.14564","article-title":"Effects of a remotely supervised resistance training program on muscle strength and body composition in adults with cystic fibrosis: randomized controlled trial","volume":"34","author":"Sosa-Pedreschi","year":"2024","journal-title":"Scand J Med Sci Sports"},{"key":"10.1016\/j.jcf.2026.03.026_bib0048","first-page":"5","article-title":"Improvement in body composition following a supervised exercise-training program of adult patients with cystic fibrosis","volume":"75","author":"Prevotat","year":"2019","journal-title":"Respir Med Res"},{"issue":"5","key":"10.1016\/j.jcf.2026.03.026_bib0049","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/ncp.10899","article-title":"Update on the management of vitamins and minerals in cystic fibrosis","volume":"37","author":"Sankararaman","year":"2022","journal-title":"Nutr Clin Pract"},{"issue":"3","key":"10.1016\/j.jcf.2026.03.026_bib0050","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jpeds.2005.06.003","article-title":"Overweight and obesity in deltaF508 homozygous cystic fibrosis","volume":"147","author":"Kastner-Cole","year":"2005","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.jcf.2026.03.026_bib0051","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jcf.2022.03.010","article-title":"Obesity in cystic fibrosis: prevalence, trends and associated factors data from the US cystic fibrosis foundation patient registry","volume":"21","author":"Szentpetery","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.026_bib0052","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s10620-015-3834-2","article-title":"Nutritional status improved in cystic fibrosis patients with the G551D mutation after treatment with ivacaftor","volume":"61","author":"Borowitz","year":"2016","journal-title":"Dig Dis Sci"},{"issue":"18","key":"10.1016\/j.jcf.2026.03.026_bib0053","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A CFTR potentiator in patients with cystic fibrosis and the G551D mutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2026.03.026_bib0054","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.clnu.2025.09.008","article-title":"Body mass, linear growth, and body composition before and after the introduction of elexacaftor\/tezacaftor\/ivacaftor among children and adults with cystic fibrosis","volume":"54","author":"Bader-Larsen","year":"2025","journal-title":"Clinic Nutrition"},{"issue":"5","key":"10.1016\/j.jcf.2026.03.026_bib0055","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1164\/rccm.202108-1986OC","article-title":"Clinical effectiveness of Elexacaftor\/Tezacaftor\/Ivacaftor in people with cystic fibrosis: a Clinical trial","volume":"205","author":"Nichols","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.jcf.2026.03.026_bib0056","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1513\/AnnalsATS.202501-103OC","article-title":"Clinical effectiveness of Elexacaftor\/Tezacaftor\/Ivacaftor in 6- to 11-year-olds with cystic fibrosis: an observational study","volume":"22","author":"Pittman","year":"2025","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"10.1016\/j.jcf.2026.03.026_bib0057","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jcf.2021.11.012","article-title":"Effect of elexacaftor-tezacaftor-ivacaftor on body weight and metabolic parameters in adults with cystic fibrosis","volume":"21","author":"Petersen","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"8","key":"10.1016\/j.jcf.2026.03.026_bib0058","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41430-025-01589-y","article-title":"A systematic review of the impact of Elexacaftor\/Tezacaftor\/Ivacaftor on body composition in people with cystic fibrosis","volume":"79","author":"Kinsey","year":"2025","journal-title":"Eur J Clin Nutr"},{"issue":"12","key":"10.1016\/j.jcf.2026.03.026_bib0059","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1016\/j.clnu.2023.10.015","article-title":"A prospective study to assess the impact of a novel CFTR therapy combination on body composition in patients with cystic fibrosis with F508del mutation","volume":"42","author":"Knott-Torcal","year":"2023","journal-title":"Clinic Nutrition"},{"issue":"5","key":"10.1016\/j.jcf.2026.03.026_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2023.101466","article-title":"Effects of elexacaftor \/tezacaftor \/ ivacaftor triple combination therapy on glycaemic control and body composition in patients with cystic fibrosis-related diabetes","volume":"49","author":"Grancini","year":"2023","journal-title":"Diabetes Metab."},{"issue":"6","key":"10.1016\/j.jcf.2026.03.026_bib0061","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1002\/ppul.26388","article-title":"Larson Ode K. The impact of elexacaftor\/tezacaftor\/ivacaftor on body composition in a small cohort of youth with cystic fibrosis","volume":"58","author":"Granados","year":"2023","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2026.03.026_bib0062","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1157459","article-title":"Weight increase in people with cystic fibrosis on CFTR modulator therapy is mainly due to increase in fat mass","volume":"14","author":"Mouzaki","year":"2023","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.026_bib0063","doi-asserted-by":"crossref","first-page":"9465","DOI":"10.1038\/s41598-024-59622-2","article-title":"Elexacaftor\/tezacaftor\/ivacaftor influences body composition in adults with cystic fibrosis: a fully automated CT-based analysis","volume":"14","author":"Westholter","year":"2024","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.jcf.2026.03.026_bib0064","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.910","article-title":"The relationship between weight and pulmonary outcomes in overweight and obese people with cystic fibrosis: a retrospective observational study","volume":"5","author":"Welter","year":"2022","journal-title":"Health Sci Report"},{"issue":"4","key":"10.1016\/j.jcf.2026.03.026_bib0065","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.nut.2015.10.012","article-title":"Body composition and lung function in cystic fibrosis and their association with adiposity and normal-weight obesity","volume":"32","author":"Alvarez","year":"2016","journal-title":"Nutrition"},{"issue":"2","key":"10.1016\/j.jcf.2026.03.026_bib0066","doi-asserted-by":"crossref","DOI":"10.3390\/nu14020310","article-title":"The relationship between body composition, dietary intake, physical activity, and pulmonary status in adolescents and adults with cystic fibrosis","volume":"14","author":"Scully","year":"2022","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.jcf.2026.03.026_bib0067","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.pedneo.2023.11.006","article-title":"Pulmonary function and body composition parameters of children with cystic fibrosis from a hight complexity institution between 2015 and 2018","volume":"65","author":"Salazar-Solarte","year":"2024","journal-title":"Pediatr Neonatol"},{"key":"10.1016\/j.jcf.2026.03.026_bib0068","article-title":"Overweight and cystic fibrosis: an unexpected challenge","volume":"57 Suppl 1","author":"Gabel","year":"2022","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2026.03.026_bib0069","article-title":"Glucagon-like peptide1 receptor agonist treatment of cystic fibrosis-related diabetes complicated by obesity: a cases series and literature review","volume":"38","author":"Ahmed","year":"2024","journal-title":"J Clin Transl Endocrinol"},{"issue":"4","key":"10.1016\/j.jcf.2026.03.026_bib0070","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jcf.2019.04.001","article-title":"Cystic fibrosis dyslipidaemia: a cross-sectional study","volume":"18","author":"Nowak","year":"2019","journal-title":"J Cyst Fibros"},{"issue":"6","key":"10.1016\/j.jcf.2026.03.026_bib0071","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.jcf.2023.07.001","article-title":"Improvement of lipid and lipoprotein profiles in children and adolescents with cystic fibrosis on CFTR modulator therapy","volume":"22","author":"Yuzyuk","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.03.026_bib0072","article-title":"Cholesterol and triglyceride concentrations following 12-18 months of clinically prescribed elexacaftor-tezacaftor-ivacaftor-PROMISE sub-study","volume":"40","author":"Bass","year":"2025","journal-title":"J Clin Transl Endocrinol"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.026_bib0073","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jcf.2021.04.016","article-title":"Cardiovascular complications in cystic fibrosis: a review of the literature","volume":"21","author":"Poore","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.026_bib0074","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jcf.2021.06.010","article-title":"Preclinical atherosclerosis in cystic fibrosis: two distinct presentations are related to pancreatic status","volume":"21","author":"Nowak","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"6","key":"10.1016\/j.jcf.2026.03.026_bib0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.jand.2020.01.007","article-title":"Antioxidant micronutrients and essential fatty acids supplementation on Cystic fibrosis outcomes: a systematic review","volume":"120","author":"Simon","year":"2020","journal-title":"J Acad Nutr Diet"},{"issue":"24","key":"10.1016\/j.jcf.2026.03.026_bib0076","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1042\/CS20220450","article-title":"The fatty acid imbalance of cystic fibrosis exists at birth independent of feeding in pig and ferret models","volume":"136","author":"Uc","year":"2022","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.026_bib0077","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jcf.2025.10.011","article-title":"Persistent plasma and RBC fatty acid abnormalities in children and adolescents with cystic fibrosis on highly effective CFTR modulators","volume":"25","author":"Yuzyuk","year":"2026","journal-title":"J Cyst Fibros"},{"issue":"6","key":"10.1016\/j.jcf.2026.03.026_bib0078","doi-asserted-by":"crossref","DOI":"10.1016\/j.jand.2020.01.007","article-title":"Antioxidant micronutrients and essential fatty acids supplementation on Cystic fibrosis outcomes: a systematic review","volume":"120","author":"Simon","year":"2020","journal-title":"J Acad Nutr Diet"},{"issue":"8","key":"10.1016\/j.jcf.2026.03.026_bib0079","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJM199502233320803","article-title":"The risk of cancer among patients with cystic fibrosis. Cystic fibrosis and cancer study group","volume":"332","author":"Neglia","year":"1995","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jcf.2026.03.026_bib0080","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S1470-2045(18)30188-8","article-title":"Risk of gastrointestinal cancers in patients with cystic fibrosis: a systematic review and meta-analysis","volume":"19","author":"Yamada","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jcf.2026.03.026_bib0081","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2025.12.015","article-title":"Ageing with cystic fibrosis: challenges ahead","author":"Spelier","year":"2026","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.jcf.2026.03.026_bib0082","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2017.12.012","article-title":"Cystic fibrosis colorectal cancer screening consensus recommendations","volume":"154","author":"Hadjiliadis","year":"2018","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.jcf.2026.03.026_bib0083","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/codi.16472","article-title":"A systematic review of the colorectal microbiome in adult cystic fibrosis patients","volume":"25","author":"Gilbert","year":"2023","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.jcf.2026.03.026_bib0084","article-title":"Dietary patterns and risk of colorectal cancer: a systematic review","author":"Giovannucci","year":"2025","journal-title":"USDA Nutrit Evid System Rev (NESR) System Rev, Rapid Rev Eviden Scans"},{"issue":"5","key":"10.1016\/j.jcf.2026.03.026_bib0085","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ajcnut.2025.01.014","article-title":"Dietary-lifestyle patterns and colorectal cancer risk: global cancer update programme (CUP Global) systematic literature review","volume":"121","author":"Chu","year":"2025","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"10.1016\/j.jcf.2026.03.026_bib0086","article-title":"Risk factors for early-onset colorectal cancer: a systematic review and meta-analysis","volume":"20","author":"O'Sullivan","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.jcf.2026.03.026_bib0087","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.clnu.2023.03.018","article-title":"Ultra-processed food consumption and cancer risk: a systematic review and meta-analysis","volume":"42","author":"Isaksen","year":"2023","journal-title":"Clinic Nutrition"},{"issue":"3","key":"10.1016\/j.jcf.2026.03.026_bib0088","doi-asserted-by":"crossref","first-page":"5123","DOI":"10.1007\/s11357-025-01646-1","article-title":"Association between red and processed meat consumption and colorectal cancer risk: a comprehensive meta-analysis of prospective studies","volume":"47","author":"Ungvari","year":"2025","journal-title":"Geroscience"},{"key":"10.1016\/j.jcf.2026.03.026_bib0089","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d6617","article-title":"Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies","volume":"343","author":"Aune","year":"2011","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.jcf.2026.03.026_bib0090","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.37341","article-title":"Role of diet in colorectal cancer incidence: umbrella Review of meta-analyses of prospective observational studies","volume":"4","author":"Veettil","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jcf.2026.03.026_bib0091","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2025.106810","article-title":"Vitamin D status in young adults with cystic fibrosis on highly effective CFTR modulator therapy","volume":"253","author":"Cobb","year":"2025","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.jcf.2026.03.026_bib0092","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1158452","article-title":"Quality of dietary macronutrients is associated with glycemic outcomes in adults with cystic fibrosis","volume":"10","author":"Daley","year":"2023","journal-title":"Front Nutr"},{"issue":"3","key":"10.1016\/j.jcf.2026.03.026_bib0093","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jcf.2019.01.002","article-title":"Visceral adipose tissue is associated with poor diet quality and higher fasting glucose in adults with cystic fibrosis","volume":"18","author":"Bellissimo","year":"2019","journal-title":"J Cystic Fibros"},{"issue":"6","key":"10.1016\/j.jcf.2026.03.026_bib0094","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.jcf.2018.03.011","article-title":"Dietary intake of energy-dense, nutrient-poor and nutrient-dense food sources in children with cystic fibrosis","volume":"17","author":"Sutherland","year":"2018","journal-title":"J Cystic Fibrosis"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.026_bib0095","article-title":"Diet and the gut-lung axis in cystic fibrosis \u2013 direct & indirect links","volume":"15","author":"McKay","year":"2023","journal-title":"Gut Microb"},{"key":"10.1016\/j.jcf.2026.03.026_bib0096","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2024.107749","article-title":"Lower physical activity levels in youth with Cystic Fibrosis compared to healthy controls: a multicentre comparative study","volume":"232","author":"Kinaupenne","year":"2024","journal-title":"Respir Med"},{"issue":"3","key":"10.1016\/j.jcf.2026.03.026_bib0097","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrgastro.2015.226","article-title":"Cystic fibrosis from the gastroenterologist's perspective","volume":"13","author":"Ooi","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.jcf.2026.03.026_bib0098","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3390\/jcm11030649","article-title":"Intestinal inflammation and alterations in the gut microbiota in cystic fibrosis: a review of the current evidence, pathophysiology and future directions","volume":"11","author":"Tam","year":"2022","journal-title":"J Clin Med"},{"issue":"10","key":"10.1016\/j.jcf.2026.03.026_bib0099","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1007\/s10620-015-3842-2","article-title":"Fecal Human \u03b2-defensin 2 in children with cystic fibrosis: is there a diminished intestinal innate immune response?","volume":"60","author":"Ooi","year":"2015","journal-title":"Dig Dis Sci."},{"issue":"2","key":"10.1016\/j.jcf.2026.03.026_bib0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004664","article-title":"CFTR is a negative regulator of NFkappaB mediated innate immune response","volume":"4","author":"Vij","year":"2009","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.026_bib0101","doi-asserted-by":"crossref","DOI":"10.1038\/srep22493","article-title":"Metagenomic evidence for taxonomic dysbiosis and functional imbalance in the gastrointestinal tracts of children with cystic fibrosis","volume":"6","author":"Manor","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcf.2026.03.026_bib0102","doi-asserted-by":"crossref","DOI":"10.1038\/srep24857","article-title":"Disrupted progression of the intestinal microbiota with age in children with cystic fibrosis","volume":"6","author":"Nielsen","year":"2016","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.jcf.2026.03.026_bib0103","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jcf.2020.04.007","article-title":"Development of the gut microbiota in early life: the impact of cystic fibrosis and antibiotic treatment","volume":"19","author":"Kristensen","year":"2020","journal-title":"Journal of Cystic Fibrosis"},{"issue":"0","key":"10.1016\/j.jcf.2026.03.026_bib0104","article-title":"Development of the intestinal microbiome in cystic fibrosis in early life","volume":"0","author":"Price","year":"2023","journal-title":"MSphere"},{"issue":"2","key":"10.1016\/j.jcf.2026.03.026_bib0105","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3390\/metabo11020123","article-title":"Impact of altered gut microbiota and its metabolites in cystic fibrosis","volume":"11","author":"Thavamani","year":"2021","journal-title":"Metabolites"},{"issue":"3","key":"10.1016\/j.jcf.2026.03.026_bib0106","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3390\/nu14030480","article-title":"What do we know about the microbiome in cystic fibrosis? Is there a role for probiotics and prebiotics?","volume":"14","author":"van Dorst","year":"2022","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.026_bib0107","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12866-017-0968-8","article-title":"The altered gut microbiota in adults with cystic fibrosis","volume":"17","author":"Burke","year":"2017","journal-title":"BMC Microbiol."},{"issue":"1","key":"10.1016\/j.jcf.2026.03.026_bib0108","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-55028-7","article-title":"Gut microbiota in children with cystic fibrosis: a taxonomic and functional dysbiosis","volume":"9","author":"Coffey","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcf.2026.03.026_bib0109","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.clnesp.2023.04.008","article-title":"Profile of the intestinal microbiota of patients with cystic fibrosis: a systematic review","volume":"55","author":"de Souza Furtado","year":"2023","journal-title":"Clin Nutr ESPEN"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.026_bib0110","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s12866-021-02305-z","article-title":"Infants with cystic fibrosis have altered fecal functional capacities with potential clinical and metabolic consequences","volume":"21","author":"Eng","year":"2021","journal-title":"BMC Microbiol."},{"issue":"2","key":"10.1016\/j.jcf.2026.03.026_bib0111","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41591-019-0714-x","article-title":"Fecal dysbiosis in infants with cystic fibrosis is associated with early linear growth failure","volume":"26","author":"Hayden","year":"2020","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.jcf.2026.03.026_bib0112","doi-asserted-by":"crossref","DOI":"10.1093\/femsec\/fiw230","article-title":"Impact of cystic fibrosis disease on archaea and bacteria composition of gut microbiota","volume":"93","author":"Miragoli","year":"2017","journal-title":"FEMS Microbiol Ecol"},{"issue":"12","key":"10.1016\/j.jcf.2026.03.026_bib0113","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208171","article-title":"Gut microbiota signatures in cystic fibrosis: loss of host CFTR function drives the microbiota enterophenotype","volume":"13","author":"Vernocchi","year":"2018","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.026_bib0114","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/microorganisms7010014","article-title":"What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases","volume":"7","author":"Rinninella","year":"2019","journal-title":"Microorganisms"},{"issue":"4","key":"10.1016\/j.jcf.2026.03.026_bib0115","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jcf.2023.01.013","article-title":"The gut microbiome, short chain fatty acids, and related metabolites in cystic fibrosis patients with and without colonic adenomas","volume":"22","author":"BL","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.026_bib0116","doi-asserted-by":"crossref","first-page":"8872","DOI":"10.1038\/s41598-019-45467-7","article-title":"Antibiotic-induced decreases in the levels of microbial-derived short-chain fatty acids correlate with increased gastrointestinal colonization of Candida albicans","volume":"9","author":"Guinan","year":"2019","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.jcf.2026.03.026_bib0117","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220642","article-title":"The long-term consequences of antibiotic therapy: role of colonic short-chain fatty acids (SCFA) system and intestinal barrier integrity","volume":"14","author":"Holota","year":"2019","journal-title":"PloS One"},{"issue":"9","key":"10.1016\/j.jcf.2026.03.026_bib0118","doi-asserted-by":"crossref","DOI":"10.1038\/nmicrobiol.2016.93","article-title":"Colonic transit time is related to bacterial metabolism and mucosal turnover in the gut","volume":"1","author":"Roager","year":"2016","journal-title":"Nat Microbiol"},{"issue":"S1","key":"10.1016\/j.jcf.2026.03.026_bib0119","doi-asserted-by":"crossref","DOI":"10.1002\/ppul.26913","article-title":"The gastrointestinal microbiome, small bowel bacterial overgrowth, and microbiome modulators in cystic fibrosis","volume":"59","author":"Green","year":"2024","journal-title":"Pediatr Pulmonol."},{"issue":"9","key":"10.1016\/j.jcf.2026.03.026_bib0120","first-page":"560","article-title":"Gut bacteria in health and disease","volume":"9","author":"Quigley","year":"2013","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"8","key":"10.1016\/j.jcf.2026.03.026_bib0121","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","article-title":"Expert consensus document. The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic","volume":"11","author":"Hill","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.jcf.2026.03.026_bib0122","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1053\/j.gastro.2020.05.059","article-title":"AGA clinical practice guidelines on the role of probiotics in the management of gastrointestinal disorders","volume":"159","author":"Su","year":"2020","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.jcf.2026.03.026_bib0123","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jcf.2016.09.004","article-title":"Effect of probiotics on respiratory, gastrointestinal and nutritional outcomes in patients with cystic fibrosis: a systematic review","volume":"16","author":"Anderson","year":"2017","journal-title":"J Cystic Fibros"},{"issue":"4","key":"10.1016\/j.jcf.2026.03.026_bib0124","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s12519-017-0033-6","article-title":"Does probiotic supplementation affect pulmonary exacerbation and intestinal inflammation in cystic fibrosis: a systematic review of randomized clinical trials","volume":"13","author":"Nikniaz","year":"2017","journal-title":"World J Pediatr"},{"key":"10.1016\/j.jcf.2026.03.026_bib0125","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.clnesp.2017.01.007","article-title":"Clinical effects of probiotics in cystic fibrosis patients: a systematic review","volume":"18","author":"Van Biervliet","year":"2017","journal-title":"Clin Nutr ESPEN"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.026_bib0126","article-title":"Probiotics for people with cystic fibrosis","volume":"1","author":"Coffey","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.026_bib0127","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s12890-022-02078-9","article-title":"Gut bifidobacteria enrichment following oral Lactobacillus-supplementation is associated with clinical improvements in children with cystic fibrosis","volume":"22","author":"Ray","year":"2022","journal-title":"BMC Pulm Med"},{"issue":"9","key":"10.1016\/j.jcf.2026.03.026_bib0128","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3390\/nu9091021","article-title":"Effects of probiotics, prebiotics, and synbiotics on Human health","volume":"9","author":"Markowiak","year":"2017","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.jcf.2026.03.026_bib0129","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/19490976.2018.1534512","article-title":"Opportunistic bacteria confer the ability to ferment prebiotic starch in the adult cystic fibrosis gut","volume":"10","author":"Wang","year":"2019","journal-title":"Gut Microbes"},{"issue":"11","key":"10.1016\/j.jcf.2026.03.026_bib0130","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.clnu.2024.09.036","article-title":"The impact of a whole foods dietary intervention on gastrointestinal symptoms, inflammation, and fecal microbiota in pediatric patients with cystic fibrosis: a pilot study","volume":"43","author":"Green","year":"2024","journal-title":"Clinic Nutrition"},{"issue":"10","key":"10.1016\/j.jcf.2026.03.026_bib0131","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/s41575-022-00619-5","article-title":"Dietary management of adults with IBD - the emerging role of dietary therapy","volume":"19","author":"Fitzpatrick","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.jcf.2026.03.026_bib0132","doi-asserted-by":"crossref","first-page":"947","DOI":"10.3390\/nu11050947","article-title":"A review of dietary therapy for IBD and a vision for the future","volume":"11","author":"Green","year":"2019","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.jcf.2026.03.026_bib0133","doi-asserted-by":"crossref","first-page":"944","DOI":"10.3390\/nu12040944","article-title":"Nutrition, IBD and gut microbiota: a review","volume":"12","author":"Mentella","year":"2020","journal-title":"Nutrients"},{"issue":"8","key":"10.1016\/j.jcf.2026.03.026_bib0134","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1136\/gutjnl-2017-313750","article-title":"The low FODMAP diet: recent advances in understanding its mechanisms and efficacy in IBS","volume":"66","author":"Staudacher","year":"2017","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.jcf.2026.03.026_bib0135","doi-asserted-by":"crossref","DOI":"10.3390\/nu12123749","article-title":"The specific carbohydrate diet and diet modification as induction therapy for pediatric Crohn's Disease: a randomized diet controlled trial","volume":"12","author":"Suskind","year":"2020","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.jcf.2026.03.026_bib0136","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1007\/s10620-022-07812-1","article-title":"Cystic fibrosis-related gut dysbiosis: a systematic review","volume":"68","author":"Caley","year":"2023","journal-title":"Dig Dis Sci."},{"key":"10.1016\/j.jcf.2026.03.026_bib0137","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jsbmb.2016.11.001","article-title":"Role of vitamin D on gut microbiota in cystic fibrosis","volume":"175","author":"Kanhere","year":"2018","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"2","key":"10.1016\/j.jcf.2026.03.026_bib0138","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1210\/jc.2017-01983","article-title":"Bolus weekly vitamin D3 supplementation impacts gut and airway microbiota in adults with cystic fibrosis: a double-blind, randomized, placebo-controlled clinical trial","volume":"103","author":"Kanhere","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.jcf.2026.03.026_bib0139","doi-asserted-by":"crossref","DOI":"10.3390\/nu10091264","article-title":"Associations between flavonoid intakes and gut microbiota in a group of adults with cystic fibrosis","volume":"10","author":"Li","year":"2018","journal-title":"Nutrients"},{"issue":"24","key":"10.1016\/j.jcf.2026.03.026_bib0140","doi-asserted-by":"crossref","DOI":"10.3390\/nu15245013","article-title":"Association between dietary intake and faecal microbiota in children with Cystic Fibrosis","volume":"15","author":"Viteri-Echeverria","year":"2023","journal-title":"Nutrients"},{"issue":"10","key":"10.1016\/j.jcf.2026.03.026_bib0141","doi-asserted-by":"crossref","DOI":"10.3390\/nu12103126","article-title":"Adherence to dietary recommendations, nutrient intake adequacy and diet quality among pediatric cystic fibrosis patients: results from the GreeCF study","volume":"12","author":"Poulimeneas","year":"2020","journal-title":"Nutrients"},{"issue":"7","key":"10.1016\/j.jcf.2026.03.026_bib0142","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1136\/gut.2010.232025","article-title":"Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease","volume":"60","author":"Benjamin","year":"2011","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.jcf.2026.03.026_bib0143","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2020.05.026","article-title":"Low-fat, high-Fiber diet reduces markers of inflammation and dysbiosis and improves quality of life in patients with ulcerative colitis","volume":"19","author":"Fritsch","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.jcf.2026.03.026_bib0144","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/nutrit\/nuab062","article-title":"Are all dietary fibers equal for patients with inflammatory bowel disease? A systematic review of randomized controlled trials","volume":"80","author":"Peters","year":"2022","journal-title":"Nutr Rev."},{"issue":"6","key":"10.1016\/j.jcf.2026.03.026_bib0145","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/ajcn\/nqy041","article-title":"Dietary fiber intervention on gut microbiota composition in healthy adults: a systematic review and meta-analysis","volume":"107","author":"So","year":"2018","journal-title":"Am J Clin Nutr."},{"issue":"1","key":"10.1016\/j.jcf.2026.03.026_bib0146","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-36364-6","article-title":"Impact of CFTR modulation with ivacaftor on gut microbiota and intestinal inflammation","volume":"8","author":"Ooi","year":"2018","journal-title":"Sci Rep"},{"issue":"Pt 5","key":"10.1016\/j.jcf.2026.03.026_bib0147","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1099\/ijs.0.02873-0","article-title":"Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium","volume":"54","author":"Derrien","year":"2004","journal-title":"Int J Syst Evol Microbiol"},{"issue":"4","key":"10.1016\/j.jcf.2026.03.026_bib0148","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jcf.2025.05.006","article-title":"Fecal microbiota changes in people with cystic fibrosis after 6 months of elexacaftor\/tezacaftor\/ivacaftor: findings from the promise study","volume":"24","author":"Duong","year":"2025","journal-title":"J Cystic Fibros"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199326000937?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199326000937?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T15:44:52Z","timestamp":1781883892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199326000937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":148,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1569199326000937"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2026.03.026","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in nutritional priorities and management in people with CF","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2026.03.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}